Trade Show Story by Gravel
Tianjin Taipu Pharmaceutical Technology Development Co., Ltd logo

Tianjin Taipu Pharmaceutical Technology Development Co., Ltd

Website:
tipr.com.cn

Tianjin Taipu’s parent company, Tianjin Institute of Pharmaceutical Research Co., Ltd (TIPR), has an experience of over 60 years of in drug research, production, and sales, renowned in the Chinese pharmaceutical industry. In 2018, TIPR was acquired by China Merchants Group, whose total profit, net profit, and total assets ranks first among Chinese state-owned enterprises.TIPR has four manufacturing sites for active pharmaceutical ingredients, and Tianjin Taipu was established for cosmetics operation, but it has already cooperated with multiple well-known cosmetics brands in China.

Key products

  • PYRROLIDINYL DIAMINOPYRIMIDINE OXIDE 吡咯烷基二氨基嘧啶氧化物
  • COPPER TRIPEPTIDE-1 三肽-1铜
  • tetrahydrocurcumin 四氢姜黄素
  • Glabridinby by Chemical Synthesis 化学合成光甘草定
  • DIAMINOPYRIMIDINE OXIDE 二氨基嘧啶氧化物 亚美尼斯

Trade show appearances

1 appearance on record across 1 show.

2026
  • in-cosmetics Asia
    S70